Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
30 hedge funds and large institutions have $5.15M invested in Acer Therapeutics Inc in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 7 closing their positions.
0% more funds holding
Funds holding: 30 → 30 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
7% less call options, than puts
Call options by funds: $150K | Put options by funds: $162K
23% less capital invested
Capital invested by funds: $6.67M → $5.15M (-$1.52M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
+$255K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$180K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$152K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$73.9K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$72.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JGC
J. Goldman & Co
New York
|
-$943K |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$656K |
| 3 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$656K |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$299K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$187K |
ACER Hedge Fund Activity: Q1 2021 in Review
30 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q1 2021, worth a combined $5.15M — down 23% from $6.67M a quarter earlier.
Fund positioning in ACER was balanced in Q1 2021: 7 funds opened new positions, 7 closed out, 7 added to existing stakes and 7 trimmed.
The largest buyer was Squarepoint, opening a new position worth an estimated $255K. The largest seller was J. Goldman & Co, exiting entirely with an estimated $943K sold.
- 30 institutional investors held Acer Therapeutics Inc (ACER) as of Q1 2021, unchanged from Q4 2020.
- Funds reported $5.15M of Acer Therapeutics Inc stock for Q1 2021, down 23% quarter-over-quarter.
- 7 funds opened new Acer Therapeutics Inc positions in Q1 2021 and 7 closed out, a net change of 0 holders.
- The largest Acer Therapeutics Inc buyer in Q1 2021 was Squarepoint, an estimated $255K added.
- The largest Acer Therapeutics Inc seller in Q1 2021 was J. Goldman & Co, an estimated $943K sold.
Based on aggregated 13F filings for Q1 2021.